In human clinical prostate cancer specimens, TSPY was predominantly detected in the epithelial tumor cells, which were also positive for the tumor biomarker, alpha-methylacyl-CoA racemase (AMACR) [28]. This evidence concerns the gene AMACR and prostate cancer.